Second-site antibiotic resistance mutations in the ribosomal region of yeast mitochondrial DNA
J A Knight1, A J Courey, B Stebbins
1Department of Biological Sciences, Mount Holyoke College, 01075, South Hadley, Massachusetts, USA.
Abstract:
A large proportion of the spontaneous erythromycin resistant mutants isolated from a strain carrying a previously-induced chloramphenicol resistance mutation at cap3 do not map at ery1, the locus most often associated with mitochondrial erythromycin resistance. Most of the new mutations are also nonallelic at spil, spi2, and other known antibiotic resistance loci within the 21S rRNA gene; they are allelic with each other and define the new locus, ery2. Induced second-site erythromycin resistant mutants from the cap (r3) strain, as well as spontaneous or induced mutants from strains carrying a cap (r) 1 mutation, all tend to map at eryl. The cap (r3) mutation is apparently necessary for the expression of erythromycin resistance resulting from a second mutation at ery2.
Insights
Mitochondrial erythromycin resistance can arise from mutations at a new locus, ery2, but requires a specific chloramphenicol resistance mutation (cap3) for expression. Other mutations map to the known ery1 locus.
Area of Science:
- Mitochondrial genetics
- Antibiotic resistance mechanisms
- Molecular biology
Background:
- Erythromycin resistance in mitochondria is primarily associated with the ery1 locus within the 21S rRNA gene.
- Previous studies indicated that mutations at ery1 are the main cause of erythromycin resistance.
- The role of other genetic loci and specific pre-existing mutations in conferring antibiotic resistance remains incompletely understood.
Purpose of the Study:
- To investigate novel genetic loci responsible for spontaneous erythromycin resistance.
- To determine the genetic basis of erythromycin resistance in yeast strains with pre-existing chloramphenicol resistance mutations.
- To elucidate the interaction between chloramphenicol resistance mutations and the expression of erythromycin resistance.
Main Methods:
- Isolation and characterization of spontaneous erythromycin-resistant mutants from a yeast strain with a cap3 chloramphenicol resistance mutation.
- Genetic mapping of newly identified erythromycin resistance mutations to determine their allelic relationships and chromosomal locations.
- Analysis of induced erythromycin-resistant mutants and comparison with spontaneous mutants.
Main Results:
- A significant proportion of spontaneous erythromycin-resistant mutants did not map to the known ery1 locus.
- These new mutations were allelic to each other and defined a novel locus, designated ery2.
- Mutations at ery2 were found to be dependent on the cap3 chloramphenicol resistance mutation for the expression of erythromycin resistance.
- Induced mutants and mutants from strains with a cap1 mutation predominantly mapped to ery1.
Conclusions:
- The discovery of the ery2 locus expands our understanding of mitochondrial erythromycin resistance.
- The cap3 mutation plays a crucial role in enabling erythromycin resistance mediated by mutations at the ery2 locus.
- This suggests complex genetic interactions governing antibiotic resistance in mitochondria.
More Related Videos
09:53Author Spotlight: Advancing Techniques and Discoveries in Protein Synthesis and Assembly Through Innovative Mitochondrial Research
Published on: June 7, 2024
05:57Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays
Published on: April 26, 2024
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Mutations in Microorganisms
Animal Mitochondrial Genetics
Inhibitors of Bacterial Protein Synthesis
Development of Antibiotic Resistance
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
